VA drug formulary better oversight is required, but veterans are getting needed drugs : report to the Ranking Member, Committee on Veterans' Affairs, U.S. Senate

VA drug formulary better oversight is required, but veterans are getting needed drugs : report to the Ranking Member, Committee on Veterans' Affairs, U.S. Senate PDF Author:
Publisher: DIANE Publishing
ISBN: 1428949933
Category :
Languages : en
Pages : 39

Get Book Here

Book Description


VA Drug Formulary

VA Drug Formulary PDF Author: United States. General Accounting Office
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 42

Get Book Here

Book Description


Is the U.S Department of Veterans Affairs Meeting the Pharmaceutical Needs of Veterans?

Is the U.S Department of Veterans Affairs Meeting the Pharmaceutical Needs of Veterans? PDF Author: United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health
Publisher:
ISBN:
Category : History
Languages : en
Pages : 86

Get Book Here

Book Description


Congressional Record

Congressional Record PDF Author: United States. Congress
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1328

Get Book Here

Book Description


Monthly Catalog of United States Government Publications

Monthly Catalog of United States Government Publications PDF Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1734

Get Book Here

Book Description


Monthly Catalogue, United States Public Documents

Monthly Catalogue, United States Public Documents PDF Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 752

Get Book Here

Book Description


The Pig Book

The Pig Book PDF Author: Citizens Against Government Waste
Publisher: Macmillan
ISBN: 9780312343576
Category : Business & Economics
Languages : en
Pages : 212

Get Book Here

Book Description
A compendium of the most ridiculous examples of Congress's pork-barrel spending.

Returning Home from Iraq and Afghanistan

Returning Home from Iraq and Afghanistan PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309152852
Category : Medical
Languages : en
Pages : 193

Get Book Here

Book Description
Nearly 1.9 million U.S. troops have been deployed to Afghanistan and Iraq since October 2001. Many service members and veterans face serious challenges in readjusting to normal life after returning home. This initial book presents findings on the most critical challenges, and lays out the blueprint for the second phase of the study to determine how best to meet the needs of returning troops and their families.

VA Opioid Prescription Policy, Practice, and Procedures

VA Opioid Prescription Policy, Practice, and Procedures PDF Author: United States. Congress. Senate. Committee on Veterans' Affairs
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 109

Get Book Here

Book Description


Pain Management and the Opioid Epidemic

Pain Management and the Opioid Epidemic PDF Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459540
Category : Medical
Languages : en
Pages : 483

Get Book Here

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.